Cargando…
Astragaloside IV combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway
Astragaloside IV (AS-IV) in improving liver cirrhosis injury in rats and its effect on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mechanistic target of rapamycin (mTOR) signaling pathway were observed. Rat model of liver cirrhosis was induced by injection of carbon tetrachloride (CC...
Autores principales: | Wei, Rendong, Liu, Haidong, Chen, Ru, Sheng, Yunjian, Liu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307369/ https://www.ncbi.nlm.nih.gov/pubmed/30651810 http://dx.doi.org/10.3892/etm.2018.6966 |
Ejemplares similares
-
Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway
por: Zhang, Xiao‐Qing, et al.
Publicado: (2019) -
Astragaloside IV Protects from PM2.5-Induced Lung Injury by Regulating Autophagy via Inhibition of PI3K/Akt/mTOR Signaling in vivo and in vitro
por: Pei, Caixia, et al.
Publicado: (2021) -
Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
por: Zaman, Qumar, et al.
Publicado: (2022) -
PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011) -
Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014)